Navigation Links
KGI Announces BIO President Greenwood to Address Health Care Reform and the Presidential Race at Simon Ramo Lecture
Date:2/12/2008

CLAREMONT, Calif., Feb. 12 /PRNewswire/ -- Keck Graduate Institute (KGI) today announced that James Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), will discuss "The American Health Care System & the Presidential Race: Who Will Regulate, Who Will Innovate?" at the 7th Annual Simon Ramo Distinguished Lecture Series on Wednesday, March 26, 2008, at 4 pm.

"We are thoroughly delighted that Jim Greenwood will serve as our guest speaker at this year's event," said Sheldon Schuster, Ph.D., KGI's president. "Health care reform is one of the most pressing issues facing our country. How it is addressed will affect all of us. The Simon Ramo Lecture is an example of KGI's commitment to provide important insights into the world of biotechnology and health care. Because KGI combines science and business to educate tomorrow's leaders in the life sciences, it is critical that we understand how federal policy may affect both. Jim's leadership at BIO and his experience with health care legislation on Capitol Hill give him a unique view of the reform process and the platforms of each candidate."

Greenwood joined BIO in January 2005 after representing Pennsylvania's Eighth District in the U.S. House of Representatives from 1993 to 2005. A senior member of the Energy and Commerce Committee, he was widely viewed as a leader on health care and the environment. Before joining Congress, Greenwood served six years in the Pennsylvania General Assembly (1980-86) and six years in the Pennsylvania Senate (1986-1993).

BIO represents more than 1,150 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. BIO also produces the annual BIO International Convention, the world's largest ga
'/>"/>

SOURCE Keck Graduate Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Rigel Announces Fourth Quarter and Year End 2007 Financial Results
2. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
3. PAREXEL International Announces 2-For-1 Stock Split
4. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
5. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
6. AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
7. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
8. Genta Announces Common Stock Offering of Approximately $3.1 Million
9. Chakshu Research Announces Appointment of Dr. Randall Olson as Director
10. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
11. Exelixis Announces February 14 Webcast of Its Fourth Quarter and Full Year 2007 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a ... target the underlying mechanisms of cancer, today reported financial ... 31, 2014. Effective July 17, 2014, the ... to December 31. As a result of that change, ... quarter and the seven months ended December 31, 2014, ...
(Date:3/3/2015)... NASA astronaut Scott Kelly , who is ... a year living and working on the International Space Station, ... 7 a.m. EDT Monday, March 9. Kelly will ... the final weeks of his training. The interviews will be ... highlighting his mission training and previous spaceflights. To ...
(Date:3/3/2015)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several ... projects in North America , the ... "Bidding activity in 2015 continues to be robust" said ... year for bidding in 2014, we are pleased to see the ... the organization,s renewed focus on select market segments where we can ...
(Date:3/3/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... Executive Officer of Neurocrine Biosciences, will be presenting at ... The live presentation takes place on Tuesday, March ... be webcast and may be accessed on the Company,s ... are encouraged to visit the website approximately 5 minutes ...
Breaking Biology Technology:Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2
... BERKELEY HEIGHTS, N.J., Oct. 18 Genta,Incorporated (Nasdaq: ... preclinical,data on Genasense(R) (oblimersen sodium) Injection, its lead ... and Therapeutics",conference that will take place from October ... is jointly sponsored by the U.S. National Cancer,Institute ...
... Consortium today published analyses of its second-generation map ... more markers than the initial version unveiled in ... the consortium describes how the higher resolution map ... in common diseases, explore the structure of human ...
... BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced ... dihydrochloride), Naglazyme(R),(galsulfase), and Aldurazyme(R) (laronidase) will be presented ... of Human Genetics in San Diego,California, October 23-27, ... below:, Platform Presentation - Session 59 - ...
Cached Biology Technology:Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC 'Targets' Conference 2Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC 'Targets' Conference 3Consortium publishes Phase II map of human genetic variation 2Consortium publishes Phase II map of human genetic variation 3Consortium publishes Phase II map of human genetic variation 4Consortium publishes Phase II map of human genetic variation 5Consortium publishes Phase II map of human genetic variation 6Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics 2Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics 3Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics 4
(Date:2/24/2015)... NEW YORK , Feb. 24, 2015 This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
(Date:2/19/2015)... 2015 Research and Markets ( ... "Military Electro-Optical / Infrared Systems Market by ... - Forecast to 2020" report to their ... market is expected to reach $16.35 billion by ... This report segments the military electro-optical/infrared systems ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... filed provisional patent 62/113114 for DISTRIBUTED METHOD ... The patent further establishes NXT-ID,s position in ... intellectual property portfolio the ability for multiple devices to ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... Bacteria normally found 30km above the earth have been ... stratosphericus a microbe commonly found in high concentrations ... is a key component of a new ,super, biofilm that ... University. , Isolating 75 different species of bacteria from the ...
... muscle . . . ,Researchers at the Bio-SANS ... variation and small-angle neutron scattering to get a first ... synthetic complexes. The unique properties of polyelectrolyte materials are ... of membrane -- three-dimensional bio-scaffolds to grow cells for ...
... One of the greatest biological threats to tropical coral reefs ... ( Acanthaster planci ). Outbreaks can consume live corals over ... reef fish populations, and reduce the aesthetic value of coral ... 30 years of research, the triggers and spread of COT ...
Cached Biology News:Superbugs from space offer new source of power 2Feb. 21, 2012, story tips 2Feb. 21, 2012, story tips 3Coral-eating sea star invaders turn out to be locals 2
This application changes sensitive keywords in an FCS file to remove patient information. It was contributed by Dr. David Miller....
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Biology Products: